The FreeStyle Libre 2 requires the sensor to be scanned for readings ... scan CGMs that require the CGM to be scanned often ...

Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

The Food and Drug Administration cleared Abbott’s Freestyle Libre 2 and 3 for integration with AID systems in March 2023. Earlier this year, Abbott integrated its FreeStyle Libre 2 Plus sensor with ...

Given every human being is totally unique, it’s no surprise our bodies often behave in different ways. So, while you should ...

[Harley] decided not to wait and managed to interface an Abbot FreeStyle Libre sensor with the Apple watch. The sensor doesn’t directly read glucose continuously, but it does allow for more ...

Abbott’s industry partners seem to view these collaborations ... Abbott’s FreeStyle Libre products have more than six million users who have type 1 or type 2 diabetes. She added that the ...

Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...

The planned launch of Omnipod 5 with Abbott's Freestyle Libre 2 Plus sensor is likely to drive further growth in the U.S. markets.

The results were further supported by data from continuous glucose monitoring (CGM; Freestyle Libre Pro iQ), which was used by approximately 80% of patients in the study and reported in a separate ...

had cleared the Libre Rio, a new over-the-counter (OTC) CGM option for type 2 diabetes patients who do not use insulin (the FreeStyle Libre targets insulin and non-insulin users). A simpler ...